P104 total nasal symptom score improvement with benralizumab for patients with severe, eosinophilic asthma

Patients with asthma often experience nasal symptoms, from comorbid allergic rhinitis and sinusitis to nasal polyposis. We evaluated reductions in nasal symptoms as a function of baseline blood eosinophil counts (BEC) for patients in a Phase IIb study of benralizumab.

Source: Annals of Allergy, Asthma and Immunology - October 31, 2019 Category: Allergy & Immunology Authors: B. Chipps, J. Corren, E. Israel, P. Barker, J. Kreindler, P. Newbold Source Type: research